http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005012358-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8669bb1220797bee29b5dd17b3c8d366
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3780594145f618eb63e1a0a18012a995
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4f6be7b5f316f050e9151b3afd8936f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42f37200916a2320579a0ce64d59dbc4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a618784cec8b20dbb4ea42ecbacaad52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4355e254e5582088603a1ba7eb636a44
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-732
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2833
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2004-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8b6cb9353925162a1233ceb80dc8b13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8e41bcd5b4c8efbc4d22602c37aa7b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d63fa67c952b52df640027add7884452
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3dac450dfc82890fb60f4c7020f0b886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f09f3bd6d0e6f42ad380a00db25f8576
publicationDate 2005-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2005012358-A2
titleOfInvention Use of adcc-optimized antibodies for treating weak patients
abstract The invention concerns the use of human or humanized chimeric monoclonal antibodies which are produced in selected cell lines, said antibodies bringing about a high ADCC activity as well as a high secretion of cytokines and interleukins, for treating underpopulations of so-called weak-response patients exhibiting CD16 FCGR3A-158F homozygote or FCGR3A-158V/F heterozygote polymorphism.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009519302-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8025879-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1960549-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010525037-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8080415-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8084222-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8357369-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1960549-A1
priorityDate 2003-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1738118
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410539
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24139
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410541
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6713579
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410540
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128571533
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14258306
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID94270
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66686818
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10679
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226640394
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409117
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226762988
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399383
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21881946
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226762987
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409529
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399382
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6140
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID994
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3034656
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226494647

Total number of triples: 76.